Latest news for Centogene (OTC:CNTGF) Stock

Centogene NV is a United States-based company engaged in data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. The company operates in two segments: pharmaceutical and diagnostics. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its diagnostics segment provides targeted genetic sequencing and diagnostics services to patients. Its geographic regions are Europe, the Middle East, North America, and Latin America.

Centogene NV

Press Releases

CENTOGENE Data on Novel Genetic Risk Factor for Parkinson's Disease in The Lancet Neurology

Comments

Centogene

News

Latest news for Centogene (OTC:CNTGF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga